The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.
 
Matthew Steven Davids
Honoraria - Research to Practice
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Ascentage Pharma; AstraZeneca; BeiGene; Celgene; Genentech; Gilead Sciences; Janssen; MEI Pharma; Pharmacyclics; Syros Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Ascentage Pharma; AstraZeneca; Bristol-Myers Squibb (Inst); Genentech (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Surface Oncology (Inst); TG Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Abbvie; BeiGene; Genentech; Janssen; TG Therapeutics
 
Kerry Anne Rogers
Consulting or Advisory Role - Acerta Pharma; AstraZeneca; Pharmacyclics
Research Funding - Abbvie (Inst); Genentech (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Svitlana Tyekucheva
No Relationships to Disclose
 
Samantha Pazienza
No Relationships to Disclose
 
Sarah K Renner
No Relationships to Disclose
 
Josie Montegaard
No Relationships to Disclose
 
Michael Rocchio
No Relationships to Disclose
 
Udochukwu Ihuoma
No Relationships to Disclose
 
Caron A. Jacobson
Honoraria - Kite/Gilead; Kite/Gilead; Kite/Gilead; Kite/Gilead
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Kite/Gilead; Kite/Gilead; Kite/Gilead; Kite/Gilead; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Precision Biosciences; Precision Biosciences; Precision Biosciences; Precision Biosciences
Speakers' Bureau - Axis Pharma; Axis Pharma; Clinical Care Options.; Clinical Care Options.
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Cowen; Cowen; Cowen; Cowen; Kite/Gilead; Kite/Gilead; Kite/Gilead; Kite/Gilead; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
 
David Christopher Fisher
Consulting or Advisory Role - Genentech; Gilead Sciences; Kyowa Hakko Kirin; verastem
 
Jennifer R. Brown
Honoraria - Janssen; Teva
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Catapult Therapeutics; Dynamo Therapeutics; Gilead Sciences; Juno/Celgene; Kite, a Gilead company; Loxo; Octopharma; Pharmacyclics; Roche/Genentech
Research Funding - Gilead Sciences; Loxo; Sunesis Pharmaceuticals; Verastem
Other Relationship - Invectys; MorphoSys
 
Philip A. Thompson
No Relationships to Disclose